Scaling up same‑visit hepatitis C testing and treatment in Canada

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational implementation project maps current hepatitis C testing and treatment workflows, identifies barriers and facilitators, and co-designs practical tools with stakeholders to support point-of-care testing. The team will work across key settings that serve people at higher risk (e.g., harm-reduction sites, correctional settings, Indigenous health centres) to pilot integration of rapid antibody and RNA tests. Methods include process mapping, qualitative interviews with patients, providers and policymakers, and development of implementation strategies and knowledge-translation resources. Findings will inform national scale-up plans for single-visit diagnosis and treatment initiation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals aged ≥18 years who have a risk factor for HCV acquisition or are attending a site that provides services to people with an HCV acquisition risk.
* Service providers and managers who are currently employed at a site providing HCV-related services, involved in or supervising the delivery of HCV-related services.
* Policymaker must hold a position in local, provincial, or national government or a health authority that influences HCV testing/treatment policies and be able to provide insights into the strategic planning and funding for HCV care.
* Laboratory and quality assurance stakeholders must hold a role in laboratory services, quality assurance, or regulatory oversight of point-of-care testing at the provincial, national, or organizational level.

Exclusion Criteria:

* Younger than 18 years old

Where it's running

• Anonyme L'Unite D'Intervention
  Montreal, Quebec, Canada Recruiting
• L'Anonyme
  Montreal, Quebec, Canada Recruiting
• McGill University
  Montreal, Quebec, Canada Active not recruiting
• Indigenous Health Centre of Tiohtià:ke
  Montreal, Quebec, Canada Not yet recruiting
• Centre de réadaptation en dépendance de Québec (CRDQ)
  Québec, Quebec, Canada Not yet recruiting
• Medicins du Monde
  Montreal, Canada Not yet recruiting

Study contacts

• Principal investigator: Guillaume Fontaine, RN, PhD — McGill University
• Study coordinator: Meagan Mooney, RN, MA, BSc
• Email: meagan.mooney@mail.mcgill.ca
• Phone: 514-994-9298

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Liver-protective nutritional supplement for people with liver disease from chronic hepatitis C

  This project will test whether a daily supplement combining resveratrol, quercetin, taurine, inulin, and whey protein helps people with liver disease from chronic hepatitis C over 12 weeks compared with whey protein alone.

  Recruiting at 2 sites University of Guadalajara · Guadalajara, Jalisco and 1 other locations · NCT07487623

• Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide

  This project will see if starting bulevirtide changes bile acids and gut bacteria in adults with chronic hepatitis D who are already on hepatitis B therapy.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07429864

• MagIA H3S multiplex rapid blood test for HIV, hepatitis B and C, and syphilis

  This project will test a single blood-based point-of-care test that checks for HIV, hepatitis B and C, and syphilis using serum or plasma samples from people at sites in Ivory Coast and Kenya.

  Recruiting at 2 sites MagIA Diagnostics · Abidjan and 1 other locations · NCT07170748

• Triple HIV/HBV/HCV screening alert in primary care

  Doctors in primary care will test a new EMR alert that suggests screening for HIV, HBV, and HCV when ordering blood tests for adults.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT07031219

• Untreated or Unknown HBV, HDV, and HCV in South-East Austria: See if People Need Care

  This study looks at past test results to see how many people in South-East Austria have hepatitis B, hepatitis D coinfection, or hepatitis C that hasn’t been treated yet or isn’t known, and then invites them for care.

  Recruiting Medical University of Graz · Graz, Styra · NCT06834178

• Preventing Hepatitis C in Kidney Transplant Recipients from Infected Donors

  This study is testing whether starting Hepatitis C medication before or after a kidney transplant from an infected donor can better prevent infection in kidney transplant recipients.

  Recruiting at 7 sites Johns Hopkins University · La Jolla, California and 8 other locations · NCT05653232

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.